According to the existing studies, the development of pulmonary fibrosis in the patients with SARS-CoV-2 infection is accompanied by the increased expression of cytokines such as TGF-β, TNF-α, IL-1β, IL-6 and IL-13. Here, IL6 is linked to pulmonary fibrosis.